Semi Annual Review of the FTSE Med 100 Index

Athens, 15 November 2013
Semi Annual Review of the
FTSE Med 100 Index



The Advisory Committee of the Common Regional Index FTSE Med 100 Index carried out a detailed review on the index's performance for the half-year period from April 2013 until October 2013, according to the Ground Rules of the said Index.

During the current review, and according to the Ground Rules, there were six (6) additions and two (2) deletions of index constituents.

In detail the changes are:

  • Additions
    • K+G Complex Ltd.
    • Louis
    • Interfund Investments
    • Apollo Investment Fund Ltd
    • CyTrustees Investment PCL
    • SFS Group Public Co. Ltd
  • Deletions
    • Laiki Capital PCL
    • Coca-Cola HBC AG